Statistical considerations when using a composite endpoint for comparing treatment groups
Author:
Affiliation:
1. Universitat Politècnica de Catalunya; Barcelona Spain
2. Department of Biostatistics; Harvard School of Public Health
Publisher
Wiley
Subject
Statistics and Probability,Epidemiology
Reference23 articles.
1. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial;Tardif;The Lancet,2008
2. Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field;Wittkop;Clinical Trials,2010
3. Breastfeeding plus infant zidovudine prophylaxys for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana. A randomized trial: the Mashi Study;Thior;JAMA,2006
4. Methodological discussions for using and interpreting composite end points are limited, but still identify major concerns;Ferreira-González;Journal of Clinical Epidemiology,2007
5. Composite outcomes in randomized trials. Greater precision but with greater uncertainty?;Freemantle;Journal of the American Medical Association,2003
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sample size calculation for mixture model based on geometric average hazard ratio and its applications to nonproportional hazard;Pharmaceutical Statistics;2023-12-28
2. An external validation of the Kidney Donor Risk Index in the UK transplant population in the presence of semi-competing events;Diagnostic and Prognostic Research;2023-11-21
3. Dealing With Nonproportional Hazards in Coronary Revascularisation Studies;Canadian Journal of Cardiology;2023-07
4. Generalised pairwise comparisons for trend: An extension to the win ratio and win odds for dose-response and prognostic variable analysis with arbitrary statements of outcome preference;Statistical Methods in Medical Research;2022-12-26
5. Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights;Trials;2022-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3